Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Technology appraisal guidance
Reference number: TA261
Published: 25 July 2012

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
01 June 2012
(216.32 Kb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 28 May 2012